Please use this identifier to cite or link to this item: https://hdl.handle.net/11000/32545
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRosendo, Luana M.-
dc.contributor.authorRosado, Tiago-
dc.contributor.authorZandonai, Thomas-
dc.contributor.authorRincon, Karem-
dc.contributor.authorPeiró, Ana-
dc.contributor.authorBarroso, Mário-
dc.contributor.authorGallardo, Eugenia-
dc.contributor.otherDepartamentos de la UMH::Farmacología, Pediatría y Química Orgánicaes_ES
dc.date.accessioned2024-07-18T10:32:51Z-
dc.date.available2024-07-18T10:32:51Z-
dc.date.created2024-05-29-
dc.identifier.citationInternational Journal of Molecular Sciences 2024, nº 25, 5925.es_ES
dc.identifier.issn1422-0067-
dc.identifier.urihttps://hdl.handle.net/11000/32545-
dc.description.abstractThis review emphasises the importance of opioid monitoring in clinical practice and advocates for a personalised approach based on pharmacogenetics. Beyond effectively managing pain, meticulous oversight is required to address concerns about side effects, specially due to opioidcrisis- related abuse and dependence. Various monitoring techniques, along with pharmacogenetic considerations, are critical for personalising treatment and optimising pain relief while reducing misuse and addiction risks. Future perspectives reveal both opportunities and challenges, with advances in analytical technologies holding promise for increasing monitoring efficiency. The integration of pharmacogenetics has the potential to transform pain management by allowing for a precise prediction of drug responses. Nevertheless, challenges such as prominent pharmacogenetic testing and guideline standardisation persist. Collaborative efforts are critical for transforming scientific advances into tangible improvements in patient care. Standardised protocols and interdisciplinary collaboration are required to ensure consistent and evidence-based opioid monitoring. Future research should look into the long-term effects of opioid therapy, as well as the impact of genetic factors on individual responses, to help guide personalised treatment plans and reduce adverse events. Lastly, embracing innovation and collaboration can improve the standard of care in chronic pain management by striking a balance between pain relief and patient safetyes_ES
dc.formatapplication/pdfes_ES
dc.format.extent32es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectchronic paines_ES
dc.subjectopioidses_ES
dc.subjectmonitoringes_ES
dc.subjectpharmacogeneticses_ES
dc.subjectclinical implicationses_ES
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicina::615 - Farmacología. Terapéutica. Toxicología. Radiologíaes_ES
dc.titleOpioid Monitoring in Clinical Settings: Strategies and Implications of Tailored Approaches for Therapyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttps://doi.org/10.3390/ijms25115925es_ES
Appears in Collections:
Artículos Farmacología, Pediatría y Química Orgánica


Thumbnail

View/Open:
 Opioid Monitoring in Clinical Settings Strategies and Implications.pdf

380,37 kB
Adobe PDF
Share:


Creative Commons ???jsp.display-item.text9???